$15MSeries B, 6 August 2025
Funds will pay for a Phase 2b trial starting Q4 2025.
- Amount
- $15M
- Stage
- Series B
- Announced
- 6 August 2025
- Use of funds
- Funds will pay for a Phase 2b trial starting Q4 2025.
- Checked
- Announced by the company
- Sources
- Retension Pharmaceuticals raises USD 15M (date approx) businesswire.com
Retension Pharmaceuticals raises USD 15M (date approx) pulse2.com